$TNDM
TANDEM DIABETES CARE INC

2015 Q2 Form 10-Q Financial Statement

#000156459015003133 Filed on April 30, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q4
Revenue $15.71M $12.31M $17.89M
YoY Change 53.17% 52.59% 74.61%
Cost Of Revenue $10.91M $9.500M $11.40M
YoY Change 60.23% 31.96% 25.27%
Gross Profit $4.801M $2.808M $6.537M
YoY Change 39.24% 223.88% 450.25%
Gross Profit Margin 30.57% 22.81% 36.54%
Selling, General & Admin $19.60M $19.36M $20.10M
YoY Change 8.47% 7.28% 40.56%
% of Gross Profit 408.23% 689.28% 307.48%
Research & Development $3.873M $3.863M $3.900M
YoY Change 4.73% 5.46% 18.18%
% of Gross Profit 80.67% 137.57% 59.66%
Depreciation & Amortization $1.230M $1.182M $1.310M
YoY Change 23.0% 28.34% 84.51%
% of Gross Profit 25.62% 42.09% 20.04%
Operating Expenses $23.47M $23.22M $24.04M
YoY Change 7.84% 6.98% 36.19%
Operating Profit -$18.67M -$20.41M -$17.50M
YoY Change 1.93% -2.05% 6.31%
Interest Expense -$900.0K -$800.0K -$900.0K
YoY Change 0.0% -27.27% -87.5%
% of Operating Profit
Other Income/Expense, Net -$862.0K -$798.0K
YoY Change -1.93% -29.0%
Pretax Income -$19.50M -$21.20M -$18.40M
YoY Change 1.56% -3.64% -22.03%
Income Tax $100.0K
% Of Pretax Income
Net Earnings -$19.53M -$21.21M -$18.47M
YoY Change 1.75% -3.43% -21.8%
Net Earnings / Revenue -124.37% -172.31% -103.22%
Basic Earnings Per Share
Diluted Earnings Per Share -$6.500M -$7.310M -$7.708M
COMMON SHARES
Basic Shares Outstanding 29.80M 23.71M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $97.70M $116.4M $67.30M
YoY Change 3.61% 5.05% -48.03%
Cash & Equivalents $45.90M $62.55M $31.18M
Short-Term Investments $51.80M $53.80M $36.10M
Other Short-Term Assets $4.200M $4.000M $3.900M
YoY Change -8.7% 0.0% 0.0%
Inventory $14.70M $13.58M $11.91M
Prepaid Expenses
Receivables $7.500M $5.226M $7.652M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $124.1M $139.2M $90.75M
YoY Change 8.46% 8.41% -39.09%
LONG-TERM ASSETS
Property, Plant & Equipment $14.30M $12.93M $12.58M
YoY Change 14.62% 19.55% 27.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $700.0K $692.0K $691.0K
YoY Change 20.73% 15.69% 7.47%
Total Long-Term Assets $17.20M $15.98M $15.71M
YoY Change 10.3% 13.87% 18.8%
TOTAL ASSETS
Total Short-Term Assets $124.1M $139.2M $90.75M
Total Long-Term Assets $17.20M $15.98M $15.71M
Total Assets $141.3M $155.1M $106.5M
YoY Change 8.68% 8.94% -34.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.000M $4.087M $1.949M
YoY Change 58.67% 99.04% -17.13%
Accrued Expenses $10.60M $2.586M $2.920M
YoY Change 528.55% 73.71% 55.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.50M $18.77M $18.09M
YoY Change 40.04% 42.89% 23.94%
LONG-TERM LIABILITIES
Long-Term Debt $29.50M $29.50M $30.00M
YoY Change 0.34% 0.34% 2.04%
Other Long-Term Liabilities $5.600M $2.102M $1.658M
YoY Change 549.71% 188.45% 108.55%
Total Long-Term Liabilities $35.10M $2.102M $31.66M
YoY Change 3972.27% 188.45% 3882.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.50M $18.77M $18.09M
Total Long-Term Liabilities $35.10M $2.102M $31.66M
Total Liabilities $53.60M $52.88M $51.89M
YoY Change 15.34% 17.17% 11.17%
SHAREHOLDERS EQUITY
Retained Earnings -$269.9M -$248.7M
YoY Change 41.21% 47.0%
Common Stock $372.1M $303.3M
YoY Change 1619414.32% 1318504.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $87.80M $102.2M $54.57M
YoY Change
Total Liabilities & Shareholders Equity $141.3M $155.1M $106.5M
YoY Change 8.68% 8.94% -34.37%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q4
OPERATING ACTIVITIES
Net Income -$19.53M -$21.21M -$18.47M
YoY Change 1.75% -3.43% -21.8%
Depreciation, Depletion And Amortization $1.230M $1.182M $1.310M
YoY Change 23.0% 28.34% 84.51%
Cash From Operating Activities -$18.76M -$15.42M -$15.14M
YoY Change 8.44% -9.08% 18.0%
INVESTING ACTIVITIES
Capital Expenditures -$1.750M $600.0K $850.0K
YoY Change 63.55% -62.96% -157.43%
Acquisitions
YoY Change
Other Investing Activities $2.050M -$17.67M $8.260M
YoY Change -47.03% -39.09% -261.96%
Cash From Investing Activities $300.0K -$18.27M $9.110M
YoY Change -89.29% -40.35% -238.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $217.0K
YoY Change 711.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.820M 65.07M 1.650M
YoY Change -3.7% 243161.43% -98.71%
NET CHANGE
Cash From Operating Activities -18.76M -15.42M -15.14M
Cash From Investing Activities 300.0K -18.27M 9.110M
Cash From Financing Activities 1.820M 65.07M 1.650M
Net Change In Cash -16.64M 31.38M -4.380M
YoY Change 31.96% -165.98% -104.02%
FREE CASH FLOW
Cash From Operating Activities -$18.76M -$15.42M -$15.14M
Capital Expenditures -$1.750M $600.0K $850.0K
Free Cash Flow -$17.01M -$16.02M -$15.99M
YoY Change 4.81% -13.78% 40.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7652000
CY2015Q1 us-gaap Inventory Net
InventoryNet
13581000
CY2014Q4 us-gaap Inventory Net
InventoryNet
11913000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1904000
CY2015Q1 us-gaap Assets Current
AssetsCurrent
139150000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
90751000
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 us-gaap Short Term Investments
ShortTermInvestments
53834000
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
36106000
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5226000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12581000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1658000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2663000
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
18770000
CY2015Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
29459000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31176000
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
29440000
CY2015Q1 us-gaap Liabilities
Liabilities
52877000
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2586000
CY2014Q4 us-gaap Liabilities
Liabilities
51892000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2920000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
24000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
803000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29780000
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29780000
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2505000
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2457000
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1821000
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1658000
CY2015Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
56000
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
118000
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
260000
CY2015Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
18000
CY2015Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-60000
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22936000
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
54000
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
17000
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1354000
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-481000
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-260000
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-385000
CY2015Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-933000
CY2014Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
699000
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37000
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-29000
CY2015Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-160000
CY2014Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1276000
CY2015Q1 tndm Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-151000
CY2014Q1 tndm Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-67000
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
366000
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-67000
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15422000
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16960000
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62549000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18094000
CY2015Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2546000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1949000
CY2014Q4 us-gaap Assets
Assets
106464000
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
692000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
691000
CY2015Q1 us-gaap Assets
Assets
155125000
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4087000
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12928000
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29801681
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
30000
CY2015Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9500000
CY2015Q1 us-gaap Gross Profit
GrossProfit
2808000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-21208000
CY2015Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
39000
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21169000
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21948000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
12308000
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-269923000
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
372102000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
54572000
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
102248000
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1960000
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2700000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-248715000
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
39000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2000000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
303255000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8000
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2000000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9722000
CY2015Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2102000
CY2015Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
99000
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23655000
CY2014Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
18000
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
8065000
CY2015Q1 us-gaap Interest Expense Other
InterestExpenseOther
897000
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7199000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
840000
CY2014Q1 us-gaap Interest Expense Other
InterestExpenseOther
1142000
CY2014Q1 us-gaap Gross Profit
GrossProfit
866000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1124000
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18041000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3863000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3663000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-21962000
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
23218000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
21704000
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8789000
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20410000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23655000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20838000
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25522000
CY2014Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
14000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.96
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-31000
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-798000
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1182000
CY2015Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
35000
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3771000
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19355000
CY2014Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
6000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106464000
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155125000
CY2015Q1 tndm Short Term Investments Amortized Cost
ShortTermInvestmentsAmortizedCost
53791000
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-30626000
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
921000
CY2014Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
93000
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3773000
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
188000
CY2015Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39099000
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
28833000
CY2015Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
21500000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
600000
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1620000
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
74000
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
173000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-18273000
CY2014Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
27000
CY2015Q1 tndm Proceeds From Issuance Of Secondary Public Offering Net Of Offering Costs
ProceedsFromIssuanceOfSecondaryPublicOfferingNetOfOfferingCosts
64851000
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
217000
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
65068000
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
27000
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31373000
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-47559000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124385000
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76826000
CY2015Q1 us-gaap Interest Paid
InterestPaid
863000
CY2014Q1 us-gaap Interest Paid
InterestPaid
1050000
CY2015Q1 tndm Future Minimum Annual Revenues Attainable Thereafter
FutureMinimumAnnualRevenuesAttainableThereafter
95000000
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
18000
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
88000
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1638000
CY2014Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
149000
CY2015Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9689941
CY2015Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3773000
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities in the Company&#8217;s financial statements and accompanying notes as of the date of the financial statements. Actual results could materially differ from those estimates and assumptions.</p></div>
CY2015Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-01-27
CY2015Q1 us-gaap Restructuring And Related Activities Completion Date
RestructuringAndRelatedActivitiesCompletionDate
2008-01-07
CY2014Q1 us-gaap Inventory Recall Expense
InventoryRecallExpense
1700000
CY2014Q1 tndm Product Replacement Related Costs
ProductReplacementRelatedCosts
700000
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
1000000
CY2015Q1 us-gaap Threshold Period Past Due For Writeoff Of Trade Accounts Receivable
ThresholdPeriodPastDueForWriteoffOfTradeAccountsReceivable
P120D
CY2015Q1 us-gaap Deferred Revenue
DeferredRevenue
700000
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
700000
CY2015Q1 tndm Revenue Recognition Period
RevenueRecognitionPeriod
P4Y
CY2015Q1 tndm Offered Period For Sales Return Prior To Expiration
OfferedPeriodForSalesReturnPriorToExpiration
P30D
CY2015Q1 tndm Allowance For Sales Returns
AllowanceForSalesReturns
200000
CY2014Q4 tndm Allowance For Sales Returns
AllowanceForSalesReturns
300000
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1974000
CY2015Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1332000
CY2015Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
834000
CY2015Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2472000
CY2015Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
668000
CY2015Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
1804000
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3280429
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6324549
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2015Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
53657000
CY2015Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
39000
CY2015Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
53696000
CY2015Q1 tndm Short Term Investments Accumulated Gross Unrealized Gain Before Tax
ShortTermInvestmentsAccumulatedGrossUnrealizedGainBeforeTax
43000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
36040000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
36048000
CY2014Q4 tndm Short Term Investments Amortized Cost
ShortTermInvestmentsAmortizedCost
36096000
CY2014Q4 tndm Short Term Investments Accumulated Gross Unrealized Gain Before Tax
ShortTermInvestmentsAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2014Q4 tndm Short Term Investments Accumulated Gross Unrealized Loss Before Tax
ShortTermInvestmentsAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
8091000
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7085000
CY2015Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3205000
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2288000
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2512000
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2856000
CY2015Q1 us-gaap Inventory Gross
InventoryGross
13808000
CY2014Q4 us-gaap Inventory Gross
InventoryGross
12229000
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
227000
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
316000
CY2015Q1 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
108286000
CY2015Q1 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
138000
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
66156000
CY2014Q4 us-gaap Liabilities Fair Value Disclosure Recurring
LiabilitiesFairValueDisclosureRecurring
58000
CY2015Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q1 tndm Future Minimum Annual Revenues Attainable In Next Twelve Months
FutureMinimumAnnualRevenuesAttainableInNextTwelveMonths
30000000
CY2015Q1 tndm Future Minimum Annual Revenues Attainable In Second Year
FutureMinimumAnnualRevenuesAttainableInSecondYear
50000000
CY2015Q1 tndm Future Minimum Annual Revenues Attainable In Third Year
FutureMinimumAnnualRevenuesAttainableInThirdYear
65000000
CY2015Q1 tndm Future Minimum Annual Revenues Attainable In Fourth Year
FutureMinimumAnnualRevenuesAttainableInFourthYear
80000000
CY2015Q1 us-gaap Long Term Debt
LongTermDebt
30000000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
30000000
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3771000
CY2015Q1 tndm Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
200000
CY2014 tndm Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
200000
CY2015Q1 tndm Number Of Pending Legal Proceeding
NumberOfPendingLegalProceeding
0
CY2014Q4 tndm Number Of Pending Legal Proceeding
NumberOfPendingLegalProceeding
0

Files In Submission

Name View Source Status
0001564590-15-003133-index-headers.html Edgar Link pending
0001564590-15-003133-index.html Edgar Link pending
0001564590-15-003133.txt Edgar Link pending
0001564590-15-003133-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tndm-10q_20150331.htm Edgar Link pending
tndm-20150331.xml Edgar Link completed
tndm-20150331.xsd Edgar Link pending
tndm-20150331_cal.xml Edgar Link unprocessable
tndm-20150331_def.xml Edgar Link unprocessable
tndm-20150331_lab.xml Edgar Link unprocessable
tndm-20150331_pre.xml Edgar Link unprocessable
tndm-ex101_2015033160.htm Edgar Link pending
tndm-ex311_201503318.htm Edgar Link pending
tndm-ex312_201503317.htm Edgar Link pending
tndm-ex321_201503316.htm Edgar Link pending
tndm-ex322_201503319.htm Edgar Link pending